Brief: Lyra Therapeutics Announces Positive Topline Results Of Pharmacokinetic Study Of Lyr-210 In Patients With Chronic Rhinosinusitis

Lyra Therapeutics

30/06/2021 12:04

June 30 (Reuters) - Lyra Therapeutics Inc  LYRA.O :
    * LYRA THERAPEUTICS ANNOUNCES POSITIVE TOPLINE RESULTS OF
PHARMACOKINETIC STUDY OF LYR-210 IN PATIENTS WITH CHRONIC
RHINOSINUSITIS
    * LYRA THERAPEUTICS INC - RESULTS SUPPORT 505(B)(2) NDA
PATHWAY
FOR LYR-210
    * LYRA THERAPEUTICS INC - FIRST U.S. STUDY OF LYR-210
ENROLLED
RAPIDLY

Source text for Eikon:  ID:nGNXbfWRlw 
Further company coverage:  LYRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))